Search
Inovio Pharmaceuticals Inc
INOAdd to Watchlist
1.185USD
-0.065-5.20%
Market hours 09/24, 14:11（ET）
97.49MMarket Cap
LossP/E TTM
Inovio Pharmaceuticals Inc (INO) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals Inc in the past month.
Buy
1 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
3.167USD+145.48%
INO Analyst Recommendation Trends
In the current month, INO has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. INO average Analyst price target in the last month is 3.167.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
2
2
2
2
2
1
2
2
2
2
2
2
2
1
1
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
5
6
6
6
6
6
INO Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, INO EPS is projected to reach -0.203 in FY2026Q3, following reported EPS of -0.074 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.36
-0.35
-0.22
-0.20
-0.19
Actual
0.06
-0.28
-0.07
--
--
Surprise
+116.96%
+18.62%
+66.00%
--
--
FAQs
What is Inovio Pharmaceuticals Inc's price target?
Analysts forecast that Inovio Pharmaceuticals Inc's price target is USD 3.17, with the highest forecast at USD 4.00 and the lowest forecast at USD 2.50.
How have Inovio Pharmaceuticals IncINO's recent earnings per share performed?
The market expectation was USD -0.07, while Inovio Pharmaceuticals IncINO's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Inovio Pharmaceuticals Inc?
Based on the ratings of Inovio Pharmaceuticals Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.